Table S1 contains two items that require correction. The OMV vaccine given subcutaneously is listed as providing 0% protection against challenge; in fact, it provided 60% protection. Additionally, the challenge information should indicate 1000 CFU by aerosol instead of 5000 CFU intranasally.
Please view the correct Table S1 here:
Click here for additional data file. (232KB, doc)
Footnotes
No competing interests declared.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Click here for additional data file. (232KB, doc)